PRZ-SITAGLIPTIN
Analogs of PRZ-SITAGLIPTIN
Find cheaper analogs and generic equivalents for PRZ-SITAGLIPTIN.
Active Ingredient: SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)
Product Overview
About PRZ-SITAGLIPTIN
PRZ-SITAGLIPTIN is a prescription medication containing the active ingredient SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE), a dipeptidyl peptidase-4 (DPP-4) inhibitor. It is used in the treatment of type 2 diabetes mellitus to improve glycemic control.
Key Benefits & Uses
- Improves glycemic control in patients with type 2 diabetes mellitus
- Reduces HbA1c levels and fasting plasma glucose levels
- May be used as monotherapy or in combination with other antidiabetic agents
Active Ingredient & Action
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) works by inhibiting the enzyme DPP-4, which is responsible for the inactivation of incretin hormones. This leads to an increase in the levels of incretin hormones, which in turn stimulates the release of insulin and decreases the release of glucagon in a glucose-dependent manner. This results in improved glycemic control and reduced HbA1c levels.
Important Notes
PRZ-SITAGLIPTIN should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions. Patients with a history of pancreatitis or pancreatic cancer should not use PRZ-SITAGLIPTIN. Common side effects include headache, nausea, and diarrhea. Patients should be monitored for signs of hypoglycemia, especially when used in combination with other antidiabetic agents.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.